MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$1,982.231K
EPS
-$0.08
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-05-31
2026-02-28
2025-11-30
2025-08-31
Revenue
0
20
0
169*
Cost of goods sold
0
0
0
-1*
Gross profit
0
20
0
170*
Research and development
970.834
475.388
671.34
1,357*
General and administrative
1,022.97
996.515
902.291
1,157*
Total operating expenses
1,993.804
1,471.903
1,573.631
2,514*
Loss from operations
-1,993.804
-1,451.903
-1,573.631
-2,344*
Interest income
0.837
1.769
0.012
3*
Unrealized gain on marketable securities
0
0
-22.093
87*
Total other income (gain)
0.837
1.769
-22.081
90*
Net loss before income taxes
-1,992.967
-1,450.134
-1,595.712
-
Income taxes
0.014
2.598
1.791
-
Net loss
-1,992.981
-1,452.732
-1,597.503
-2,254*
Less net loss attributable to non-controlling interest
-1.779
-2.753
-2.496
-3*
Net loss attributable to lexaria shareholders
-1,991.202
-1,449.979
-1,595.007
-2,251*
Foreign currency translation adjustment
8.971
20.635
-5.744
-13*
Total comprehensive loss
-1,982.231
-1,429.344
-1,600.751
-2,264
Diluted EPS
-0.08
-0.06
-0.07
-0.119
Diluted Average Shares
24,805,924
24,443,846
21,376,029
19,029,323
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Total comprehensive
loss
-$1,982.231K
(47.17%↑ Y/Y)
Foreign currency
translation adjustment
$8.971K
(-75.87%↓ Y/Y)
Net loss
attributable to lexaria...
-$1,991.202K
(47.45%↑ Y/Y)
Less net loss
attributable to...
-$1.779K
(-17.50%↓ Y/Y)
Net loss
-$1,992.981K
(47.42%↑ Y/Y)
Interest income
$0.837K
(340.53%↑ Y/Y)
Net loss before
income taxes
-$1,992.967K
Income taxes
$0.014K
Total other income
(gain)
$0.837K
(102.08%↑ Y/Y)
Loss from operations
-$1,993.804K
(46.84%↑ Y/Y)
Total operating
expenses
$1,993.804K
(-49.19%↓ Y/Y)
General and
administrative
$1,022.97K
(-15.24%↓ Y/Y)
Research and development
$970.834K
(-64.27%↓ Y/Y)
Buy us a coffee
Lexaria Bioscience Corp. (LEXX)
Lexaria Bioscience Corp. (LEXX)